Yahoo
NasdaqCM - Delayed Quote USD

Sintx Technologies, Inc. (SINT)

1.5600 -0.0600 (-3.70%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for SINT
  • Previous Close 1.6200
  • Open 1.6400
  • Bid 2.0800 x 100
  • Ask 2.5900 x 200
  • Day's Range 1.5500 - 1.6400
  • 52 Week Range 1.4000 - 4.4600
  • Volume 41,027
  • Avg. Volume 116,565
  • Market Cap (intraday) 11.791M
  • Beta (5Y Monthly) 0.57
  • PE Ratio (TTM) --
  • EPS (TTM) -4.9100
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 9.25
  • Zacks Rating Bullish

Sintx Technologies, Inc., an advanced ceramics and biomaterials company, engages in the research, development, manufacturing, and commercialization of silicon nitride biomaterials, composites, devices, and related technologies for medical and other applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). It also provides insulators for Tier 1 aerospace suppliers; SiNAPTIC® Foot & Ankle Osteotomy Wedge System for reconstructive surgery; OEM manufacturing of spinal implants; and SiNERGY™ technology platform for bio composite and 3D printing applications. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

www.sintx.com

32

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SINT
59.59%
S&P 500 (^GSPC)
7.76%

1-Year Return

SINT
53.98%
S&P 500 (^GSPC)
9.77%

3-Year Return

SINT
98.05%
S&P 500 (^GSPC)
68.96%

5-Year Return

SINT
99.99%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 2.19M
Earnings -1.59M
Profit Margin -72.83%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

-2M
0
2M
-800.0%
-600.0%
-400.0%
-200.0%

Analyst Insights

View More

Analyst Price Targets

6.00
9.25 Average
1.5600 Current
12.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/1/2026
Analyst Ascendiant Capital
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 12 -> 12.5

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -74.24%

  • Return on Equity (ttm)

    -255.86%

  • Revenue (ttm)

    1.33M

  • Net Income Avi to Common (ttm)

    -18M

  • Diluted EPS (ttm)

    -4.9100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.59M

  • Total Debt/Equity (mrq)

    65.24%

  • Levered Free Cash Flow (ttm)

    -5.91M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: